PeptiDream Inc (4587.T)

4587.T on Tokyo Stock Exchange

17 Jan 2018
Change (% chg)

¥115 (+2.73%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


PeptiDream Inc. is principally engaged in the research and development of new pharmaceutical candidates. The Company operates its business jointly with domestic and overseas pharmaceutical companies, through the application of Peptide Discovery Platform System (PDPS), which is its own drug discovery platform system. The Company... (more)


Beta: 0.71
Market Cap(Mil.): ¥420,400.41
Shares Outstanding(Mil.): 120.11
Dividend: --
Yield (%): --


BRIEF-Peptidream announces discovery collaboration agreement with Bayer

* Peptidream announces discovery collaboration agreement with bayer

20 Nov 2017

BRIEF-PeptiDream announces discovery collaboration agreement with Bayer AG

* Says it announced today that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG

16 Nov 2017

BRIEF- PeptiDream announces change of chairman and president

* Says it appoints current president Kiichi Kubota as chairman of the board of the company

22 Aug 2017

REFILE-TABLE-Peptidream-2016/17 parent results

(Adds company forecast) Aug 9 (Reuters)- Peptidream Inc. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Jun 30, 2017 Jun 30, 2016 Jun 30, 2018 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 4.90 4.33   more than 7.00 (+13.1 pc

09 Aug 2017

BRIEF-PeptiDream to set up Osaka-based special peptide drugs JV

* Says it plans to set up Osaka-based joint venture with Shionogi & Co., Ltd and Sekisui Chemical Co., Ltd. , on Sept. 1

07 Aug 2017

Earnings vs. Estimates